Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA2 | Q9HCG7 | 9/20 | 0.38 |
| ▸ | UGCG | Q16739 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 3/20 | 0.35 |
| ▸ | GBA1 | P04062 | 3/20 | 0.35 |
| ▸ | MGAM | O43451 | 2/20 | 0.35 |
| ▸ | SI | P14410 | 2/20 | 0.35 |
| ▸ | AGL | P35573 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | GLB1 | P16278 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.33 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL18420851 | 0.98 | GBA2 (0.37) | GBA2UGCGGAAGBA1MGAM | |
| Bromide SCHEMBL28399307 | 0.98 | GBA2 (0.37) | GBA2UGCGGAAGBA1MGAM | |
| Hydrochloric Acid SCHEMBL28007328 | 0.98 | GBA2 (0.37) | GBA2UGCGGAAGBA1MGAM | |
| SCHEMBL5796366 | 0.93 | GBA1 (0.39) | GBA2GAAGBA1S1PR1S1PR3 | |
| SCHEMBL5797002 | 0.91 | EBP (0.41) | GBA2UGCGGAAGBA1S1PR1 | |
| SCHEMBL5793439 | 0.91 | EBP (0.41) | GBA2UGCGGAAGBA1S1PR1 | |
| SCHEMBL5793436 | 0.91 | EBP (0.41) | GBA2UGCGGAAGBA1S1PR1 | |
| SCHEMBL2928580 | 0.91 | EBP (0.41) | GBA2UGCGGAAGBA1S1PR1 | |
| SCHEMBL5796046 | 0.91 | EBP (0.41) | GBA2UGCGGAAGBA1S1PR1 | |
| Water SCHEMBL11786352 | 0.90 | GBA1 (0.40) | GBA2UGCGGAAGBA1S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912114-B2 | Electrochromic sunroof based on all solid-state flexible thin film electrochromic device and methods to fabricate the same | Shenzhen Guangyi Tech Co., Ltd. (CN) | 2024-02-27 | — | — | US | disclosed |
| US-11912114-B2 | Electrochromic sunroof based on all solid-state flexible thin film electrochromic device and methods to fabricate the same | Shenzhen Guangyi Tech Co., Ltd. (CN) | 2024-02-27 | — | — | US | disclosed |
| US-20230040208-A1 | ELECTROCHROMIC APERTURE AND MANUFACTURING METHOD THEREFOR, AND LENS MODULE HAVING ELECTROCHROMIC APERTURE | Shenzhen Guangyi Tech Co., Ltd. (CN) | 2023-02-09 | — | — | US | disclosed |
| US-20210249595-A1 | CONDUCTIVE BRIDGE MEMORY DEVICE, MANUFACTURING METHOD THEREOF, AND SWITCHING ELEMENT | NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY (JP) | 2021-08-12 | — | — | US | disclosed |
| EP-3809456-A1 | CONDUCTIVE-BRIDGE MEMORY DEVICE AND PRODUCTION METHOD THEREFOR, AND SWITCH ELEMENT | National University Corporation Tottori University (JP) | 2021-04-21 | — | — | EP | disclosed |
| US-10921673-B2 | Method for fabricating solid state electrochromic device, solid state electrochromic device and its applications | AMBILIGHT INC. (KY) | 2021-02-16 | — | — | US | disclosed |
| US-20210041757-A1 | METHOD FOR FABRICATING SOLID STATE ELECTROCHROMIC DEVICE, SOLID STATE ELECTROCHROMIC DEVICE AND ITS APPLICATIONS | AMBILIGHT INC. (KY) | 2021-02-11 | — | — | US | disclosed |
| US-20200406728-A1 | ELECTROCHROMIC SUNROOF BASED ON ALL SOLID-STATE FLEXIBLE THIN FILM ELECTROCHROMIC DEVICE AND METHODS TO FABRICATE THE SAME | Shenzhen Guangyi Tech Co., Ltd. (CN) | 2020-12-31 | — | — | US | disclosed |
| US-20200363692-A1 | METHOD FOR FABRICATING SOLID STATE ELECTROCHROMIC DEVICE, SOLID STATE ELECTROCHROMIC DEVICE AND ITS APPLICATIONS | AMBILIGHT INC. (KY) | 2020-11-19 | — | — | US | disclosed |
| CN-106232755-B | Adhesive sheet and optical member | 日东电工株式会社 | 2020-05-22 | — | — | CN | disclosed |
| WO-2007038360-A2 | PREPARATION OF POLYTRIMETHYLENE ETHER GLYCOL AND COPOLYMERS THEREOF | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-04-05 | — | — | WO | disclosed |
| US-20070066852-A1 | Preparation of poly(tetramethylene) glycol | THE CHEMOURS COMPANY FC, LLC | 2007-03-22 | — | — | US | disclosed |
| US-20070066854-A1 | Preparation of polytrimethylene ether glycol and copolymers thereof | THE CHEMOURS COMPANY FC, LLC | 2007-03-22 | — | — | US | disclosed |
| US-20070066852-A1 | Preparation of poly(tetramethylene) glycol | THE CHEMOURS COMPANY FC, LLC | 2007-03-22 | — | — | US | disclosed |
| US-20070066854-A1 | Preparation of polytrimethylene ether glycol and copolymers thereof | THE CHEMOURS COMPANY FC, LLC | 2007-03-22 | — | — | US | disclosed |
| US-20070019708-A1 | Hybrid vapor compression-absorption cycle | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-01-25 | — | — | US | disclosed |
| US-20070019708-A1 | Hybrid vapor compression-absorption cycle | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-01-25 | — | — | US | disclosed |
| US-20060205889-A1 | cure system composition consisting of a crosslinking agent 2-mercapto-1,3,4-thiadiazole-5-thiobenzoate and accelerators 1-butyl-3-methylimidazolinium chloride; for curing chlorinated polyethylene | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-09-14 | — | — | US | disclosed |
| WO-2006027069-A1 | METHOD FOR PRODUCING HETEROCYCLIC QUATERNARY AMMONIUM AND/OR GUANIDINIUM COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-16 | — | — | WO | disclosed |
| WO-2006027070-A1 | METHOD FOR THE PRODUCTION OF HETEROCYCLIC QUATERNARY AMMONIUM COMPOUNDS AND/OR GUANIDINE COMPOUNDS HAVING HIGH PURITY | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066854-A1 | Preparation of polytrimethylene ether glycol and copolymers thereof | PARG, PTGES3, PGD | GBA2 4209/4885UGCG 337/4885GAA 4510/4885 |
| US-20070066852-A1 | Preparation of poly(tetramethylene) glycol | PARG, PUF60, TPR | GBA2 1136/4885UGCG 6/4885GAA 1882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.